title: Diabetes and cancer I: risk, survival, and implications for screening.
abstract: Type 2 diabetes mellitus (DM) and cancer are common diseases that are frequently diagnosed in the same individual. An association between the two conditions has long been postulated. Here, we review the epidemiological evidence for increased risk of cancer, decreased cancer survival, and decreased rates of cancer screening in diabetic patients. The risk for several cancers, including cancers of the pancreas, liver, colorectum, breast, urinary tract, and endometrium, is increased in patients with DM. In a pooled risk analysis weighting published meta-analytic relative risk (RR) for individual cancer by differences in their incidence rates, we found a population RR of 0.97 (95 % CI, 0.75-1.25) in men and 1.29 (95 % CI, 1.16-1.44) in women. All meta-analyses showed an increased relative risk for cancer in diabetic men, except studies of prostate cancer, in which a protective effect was observed. The relationship between diabetes and cancer appears to be complex, and at present, a clear temporal relationship between the two conditions cannot be defined. DM also impacts negatively on cancer-related survival outcomes and cancer screening rates. The overwhelming evidence for lower cancer screening rates, increased incidence of certain cancers, and poorer prognosis after cancer diagnosis in diabetic patients dictates a need for improved cancer care in diabetic individuals through improved screening measures, development of risk assessment tools, and consideration of cancer prevention strategies in diabetic patients. Part two of this review focuses on the biological and pharmacological mechanisms that may account for the association between DM and cancer.
authors.affiliation: Department of Hematology/Oncology, Marshfield Clinic Weston Center, 3501 Cranberry Boulevard, Weston, WI 54476, USA. onitilo.adedayo@marshfieldclinic.org
authors.forename: Adedayo A
authors.initials: AA
authors.lastname: Onitilo
authors.forename: Jessica M
authors.initials: JM
authors.lastname: Engel
authors.forename: Ingrid
authors.initials: I
authors.lastname: Glurich
authors.forename: Rachel V
authors.initials: RV
authors.lastname: Stankowski
authors.forename: Gail M
authors.initials: GM
authors.lastname: Williams
authors.forename: Suhail A
authors.initials: SA
authors.lastname: Doi
mesh_terms: D048909:Diabetes Complications / Q000453:epidemiology* / Q000401:mortality; D003924:Diabetes Mellitus, Type 2; D006801:Humans; D008403:Mass Screening / Q000379:methods; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality; D012307:Risk Factors; D015996:Survival Rate